As of Nov 20
| -0.14 / -3.32%|
The 4 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 16.50, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +304.41% increase from the last price of 4.08.
The current consensus among 4 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.